doi: 10.3934/genet.2019.3.36 81
Do not take this medication if: You have a personal or family history of medullary thyroid carcinoma (Thyroid Cancer) Multiple Endocrine Neoplasia syndrome type 2 You are pregnant or plan to become pregnant You are diabetic and/or taking any medications related to lowering your blood sugar levels Specifically, if you are prescribed Insulin because the combination may increase your risk of hypoglycemia (low blood sugar) You have a history of Pancreatitis You are allergic to Semaglutide, Tirzepatide or any other GLP-1 agonist such as: Ozempic, Mounjaro, Zepbound, Rybelsus, Trulicity, Victoza, Wegovy
Esophageal Rings or Webs Some people develop thin layers of tissue inside the esophagus that can partially block food passage
Restarting or switching therapies common after GLP-1 discontinuation Among patients who discontinued tirzepatide or semaglutide within the first year of treatment, many restarted the original medication or switched to another treatment
C.JosephJ.PawarG
El principio activo de Ozempic es la semaglutida, que es un anlogo del GLP-1
